Halterman MW - Search Results

1

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y. Carew JF, et al. Among authors: halterman mw. Hum Gene Ther. 1999 Jul 1;10(10):1599-606. doi: 10.1089/10430349950017608. Hum Gene Ther. 1999. PMID: 10428205

2

Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector.

Carew JF, Federoff H, Halterman M, Kraus DH, Savage H, Sacks PG, Schantz SP, Shah JP, Fong Y. Carew JF, et al. Am J Surg. 1998 Nov;176(5):404-8. doi: 10.1016/s0002-9610(98)00231-1. Am J Surg. 1998. PMID: 9874422 Free article.

3

In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors.

D'Angelica M, Karpoff H, Halterman M, Ellis J, Klimstra D, Edelstein D, Brownlee M, Federoff H, Fong Y. D'Angelica M, et al. Cancer Immunol Immunother. 1999 Jan;47(5):265-71. doi: 10.1007/s002620050530. Cancer Immunol Immunother. 1999. PMID: 10022470 Free PMC article.

4

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Kooby DA, Carew JF, Halterman MW, Mack JE, Bertino JR, Blumgart LH, Federoff HJ, Fong Y. Kooby DA, et al. Among authors: halterman mw. FASEB J. 1999 Aug;13(11):1325-34. doi: 10.1096/fasebj.13.11.1325. FASEB J. 1999. PMID: 10428757

5

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer.

Bennett JJ, Kooby DA, Delman K, McAuliffe P, Halterman MW, Federoff H, Fong Y. Bennett JJ, et al. Among authors: halterman mw. J Mol Med (Berl). 2000;78(3):166-74. doi: 10.1007/s001090000092. J Mol Med (Berl). 2000. PMID: 10868479

6

A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.

Carew JF, Kooby DA, Halterman MW, Kim SH, Federoff HJ, Fong Y. Carew JF, et al. Among authors: halterman mw. Mol Ther. 2001 Sep;4(3):250-6. doi: 10.1006/mthe.2001.0448. Mol Ther. 2001. PMID: 11545616 Free article.

7

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.

Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF, Halterman MW, Federoff HJ, Fong Y. Delman KA, et al. Among authors: halterman mw. Ann Surg. 2002 Sep;236(3):337-42; discussion 342-3. doi: 10.1097/00000658-200209000-00010. Ann Surg. 2002. PMID: 12192320 Free PMC article.

8

Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors.

Kutubuddin M, Federoff HJ, Challita-Eid PM, Halterman M, Day B, Atkinson M, Planelles V, Rosenblatt JD. Kutubuddin M, et al. Blood. 1999 Jan 15;93(2):643-54. Blood. 1999. PMID: 9885227 Free article.

9

Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

D'Angelica M, Tung C, Allen P, Halterman M, Delman K, Delohery T, Klimstra D, Brownlee M, Federoff H, Fong Y. D'Angelica M, et al. Mol Med. 1999 Sep;5(9):606-16. Mol Med. 1999. PMID: 10551902 Free PMC article.

10

Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.

Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, Federoff H, Fong Y. Zager JS, et al. Mol Med. 2001 Aug;7(8):561-8. Mol Med. 2001. PMID: 11591892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters